Citigroup
AZR icon

Citigroup’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Citigroup’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– – – 5901
2025
Q4 		– Hold
0
– – – 6014
2025
Q3 		– Sell
-159
Closed -$1.2K – 6053
2025
Q2 		$1.2K Buy
+159
New +$2.4K ﹤0.01% 5396

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Citigroup's AZR Position: Q1 2026 in Review

Citigroup held its Azora Therapeutics, Inc. Common Stock (AZR) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5901.

Citigroup first reported a position in AZR in Q2 2025 and has held it in 1 quarter since. The position peaked at $1.2K in Q2 2025. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • Citigroup held 0 shares of Azora Therapeutics, Inc. Common Stock worth $0 as of Q1 2026.
  • Citigroup left its Azora Therapeutics, Inc. Common Stock share count unchanged in Q1 2026.
  • Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5901 holding.
  • Citigroup first reported a position in Azora Therapeutics, Inc. Common Stock in Q2 2025 and has held it in 1 quarter since.
  • Citigroup's Azora Therapeutics, Inc. Common Stock position peaked at $1.2K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.